| (210) | Number of the EPO application | 16730076 |
| (220) | Filing date of the EPO application | 2016.05.18 |
| (80) | EPO patent specification publication (B) | EPB nr. 09/2020, 2020.02.26 |
| (110) | EPO patent number | 3300500 |
| (21) | Number of the application | e 2018 0312 |
| (71) | Name(s) of applicant(s), code of the country | Amgen Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | CHEN Ning, US;
CHEN Xiaoqi, US;
CHEN Yinhong, US;
CHENG Alan C., US;
CONNORS Richard V., US;
DEIGNAN Jeffrey, US;
DRANSFIELD Paul John, US;
DU Xiaohui, US;
FU Zice, US;
HEATH Julie Anne, US;
HORNE Daniel B., US;
HOUZE Jonathan, US;
KALLER Matthew R., US;
KHAKOO Aarif Yusuf, US;
KOPECKY David John, US;
LAI Su-Jen, US;
MA Zhihua, US;
MCGEE Lawrence R., US;
MEDINA Julio C., US;
MIHALIC Jeffrey T., US;
NISHIMURA Nobuko, US;
OLSON Steven H., US;
PATTAROPONG Vatee, US;
SWAMINATH Gayathri, US;
WANG Xiaodong, US;
YANG Kevin, US;
YEH Wen-Chen, US;
DEBENEDETTO Mikkel V., US;
FARRELL Robert P., US;
HEDLEY Simon J., US;
JUDD Ted C., US;
KAYSER Frank, US; |
| (73) | Name(s) of owner(s), code of the country | AMGEN Inc., US; |
| (54) | Title of the invention | TRIAZOLE AGONISTS OF THE APJ RECEPTOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); C07D 401/04 (2006.01.01); C07D 413/04 (2006.01.01); A61K 31/4196 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 9/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.05.31 |
| (30) | Priority | 201562164106 P, 2015.05.20, US |
| (86) | International application | PCT/US2016/033088, 2016.05.18 |
| (87) | International publication | WO 2016/187308, 2016.11.24 |